Jardiance is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Empagliflozin.
| Product ID | 50090-4492_3b194971-092d-4b18-8418-8b3ef53e696f |
| NDC | 50090-4492 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Jardiance |
| Generic Name | Empagliflozin |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-08-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA204629 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | EMPAGLIFLOZIN |
| Active Ingredient Strength | 10 mg/1 |
| Pharm Classes | Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA204629 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-08-29 |
| Ingredient | Strength |
|---|---|
| EMPAGLIFLOZIN | 10 mg/1 |
| SPL SET ID: | 942a82a4-cbbd-4e44-9965-8d03f767912b |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0597-0152 | Jardiance | Empagliflozin |
| 0597-0153 | Jardiance | Empagliflozin |
| 50090-4384 | Jardiance | Empagliflozin |
| 50090-4492 | Jardiance | Empagliflozin |
| 55154-0411 | Jardiance | Empagliflozin |
| 55154-0412 | Jardiance | Empagliflozin |
| 70518-1986 | Jardiance | Empagliflozin |
| 70518-2447 | Jardiance | Empagliflozin |
| 71610-177 | Jardiance | Empagliflozin |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() JARDIANCE 88902811 not registered Live/Pending |
Boehringer Ingelheim International GmbH 2020-05-06 |
![]() JARDIANCE 79060588 3595152 Live/Registered |
Boehringer Ingelheim International GmbH 2008-09-03 |